معرفی
Hervé Enslen serves as a Research Director (equivalent to Research Professor) at the Cochin Institute, a premier biomedical research center affiliated with Université Paris Cité, INSERM, and CNRS. His statutory research position places him within the institute's cancer-focused scientific axis, contributing to France's national research infrastructure in rare disease oncology.
Dr. Enslen's research program investigates the genomic and epigenetic mechanisms driving rare tumor development, with emphasis on molecular pathogenesis and therapeutic target identification. His work bridges computational genomics and clinical oncology, focusing on understudied malignancies where conventional treatments fail. This research falls at the intersection of precision medicine, tumor heterogeneity studies, and biomarker discovery for orphan cancers.
As part of Cochin Institute's cancer research axis, he collaborates across immunology, metabolism, and cellular plasticity teams to develop integrated approaches for rare tumor characterization. His statutory researcher status indicates leadership in securing institutional funding and directing specialized research initiatives within France's national health research framework.
